You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant

  • Technology appraisal guidance
  • Reference number: TA640
  • Published:  05 August 2020
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Expected publication
  2. Declaration of interests
  3. Final draft guidance
  4. Draft guidance
  5. Invitation to participate
  6. Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 134 KB)

    Published:
    05 August 2020

Declaration of interests

  • Register of interests (PDF 155 KB)

    Published:
    05 August 2020

Final draft guidance

  • Final draft guidance

  • Final appraisal document (PDF 224 KB)

    Published:
    02 July 2020
  • Committee papers - FAD (PDF 452 KB)

    Published:
    02 July 2020

Draft guidance

  • Draft guidance

  • Appraisal consultation document (online commenting)

  • Appraisal consultation document (PDF version) (PDF 253 KB)

    Published:
    14 January 2020
  • Committee papers (PDF 7.62 MB)

    Published:
    14 January 2020
  • Public committee slides (PDF 655 KB)

    Published:
    14 January 2020

Invitation to participate

  • Final scope (PDF 162 KB)

    Published:
    14 March 2019
  • Final stakeholder list (PDF 190 KB)

    Published:
    14 March 2019

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

  • Draft scope post referral (PDF 323 KB)

    Published:
    16 November 2018
  • Draft matrix post referral (PDF 264 KB)

    Published:
    16 November 2018
Back to top